22 Recruiting Studies Using Lurbinectedin
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Lurbinectedin
A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer
📍 Northwest Georgia Oncology Centers, a Service of WellStar Cobb Hospital — Marietta, Georgia
Small-Cell Lung Cancer
View Study & Checklist ➔Study Comparing Tarlatamab With Standard of Care Chemotherapy in Relapsed Small Cell Lung Cancer
📍 University of South Alabama Mitchell Cancer Institute — Mobile, Alabama
Small Cell Lung Cancer (SCLC)
View Study & Checklist ➔Lurbinectedin + Doxorubicin In Leiomyosarcoma
📍 Mayo Arizona — Phoenix, Arizona
Advanced Soft-tissue Sarcoma
View Study & Checklist ➔Durvalumab and Lurbinectedin for the Treatment of Relapsed or Refractory Small Cell Lung Cancer
📍 Mayo Clinic in Rochester — Rochester, Minnesota
Platinum-Resistant Lung Small Cell Carcinoma
View Study & Checklist ➔Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma (SaLuDo)
📍 Mayo Clinic Hospital - Phoenix — Phoenix, Arizona
Leiomyosarcoma
View Study & Checklist ➔Lurbinectedin With Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High-Grade Neuroendocrine Cancers
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
SCLC
View Study & Checklist ➔Study of Trilaciclib and Lurbinectidin
📍 Dartmouth Hitchcock Medical Center — Lebanon, New Hampshire
Lung Cancer
View Study & Checklist ➔Lurbinectedin in FET-Fused Tumors
📍 Cedars-Sinai Medical Center — Los Angeles, California
Ewing Sarcoma
View Study & Checklist ➔Phase 1b of Lurbinectedin in Combination With Weekly Paclitaxel and Bevacizumab in Platinum-resistant Ovarian Cancer
📍 M D Anderson Cancer Center — Houston, Texas
Ovarian Cancer
View Study & Checklist ➔A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
📍 Valkyrie Clinical Trials, Inc. — Los Angeles, California
Extensive-stage Small-cell Lung Cancer
View Study & Checklist ➔Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
📍 Children's Hospital of Los Angeles — Los Angeles, California
Refractory Ewing Sarcoma
View Study & Checklist ➔A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
📍 City of Hope (City of Hope National Medical Center, City of Hope Medical Center) — Duarte, California
Small Cell Lung Cancer (SCLC)
View Study & Checklist ➔Lurbinectedin With Osimertinib in Transformed Small Cell Lung Cancer
📍 Indiana University Melvin and Bren Simon Comprehensive Cancer Center — Indianapolis, Indiana
Small Cell Lung Cancer ( SCLC )
View Study & Checklist ➔A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
📍 Highlands Oncology Group — Springdale, Arkansas
Small Cell Lung Cancer
View Study & Checklist ➔Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer
📍 Emory University Hospital Midtown — Atlanta, Georgia
Extensive Stage Lung Small Cell Carcinoma
View Study & Checklist ➔Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
📍 Alaska Oncology and Hematology — Anchorage, Alaska
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
View Study & Checklist ➔A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
📍 Yale University School of Medicine /ID# 278181 — New Haven, Connecticut
Small Cell Lung Cancer
View Study & Checklist ➔Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Small Cell Carcinoma of the Bladder
View Study & Checklist ➔LINNOVATE: Lurbinectedin, Ipilimumab and Nivolumab for Soft Tissue Sarcoma
📍 Sarcoma Oncology Research Center — Santa Monica, California
Advanced Soft-tissue Sarcoma
View Study & Checklist ➔Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
📍 VA Palo Alto Health Care System, Palo Alto, CA — Palo Alto, California
Relapsed Small Cell Lung Cancer
View Study & Checklist ➔Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer
📍 Fox Chase Cancer Center — Philadelphia, Pennsylvania
Lung Cancer
View Study & Checklist ➔A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
📍 Birmingham Hematology and Oncology Associates d/b/a Alabama Oncology /ID# 280063 — Birmingham, Alabama
Small Cell Lung Cancer
View Study & Checklist ➔